Healium Medical
Healium offers contact‑free ultrasound catheter ablation for atrial fibrillation and renal denervation, leveraging real‑time imaging and automated power control.
Private Company
Estimated funding: $5M
AI Company Overview
Healium offers contact‑free ultrasound catheter ablation for atrial fibrillation and renal denervation, leveraging real‑time imaging and automated power control.
Technology Platform
Dual‑Mode Ultrasound Technology (DMUT) integrates intravascular imaging with therapeutic ultrasound to enable non‑contact, real‑time lesion creation and automated power titration based on tissue thickness.
Opportunities
Risk Factors
Competitive Landscape
Main competitors are Medtronic, Abbott, and Boston Scientific, which dominate RF and cryo ablation; Healium differentiates through non‑contact ultrasound delivery and real‑time lesion monitoring.